In the model including all participants and a variable indicating the joint classification of lifestyle profile and APOE ε4 genotype, we could observe the same dose–response relationship between lifestyle groups and cognitive impairment among both APOE ε4 carriers and noncarriers (Fig 2). Here, APOE is linked to Cognitive impairment.